शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSETRANSGENE BIOTEK LTD.· Healthcare ServicesMediumNeutral
Announced Mon, 2 Nov, 2026 · 11:54 IST

Statutory auditor resigns; Harish Gummadi and Co appointed to fill vacancy

Auditor resigned mid-termManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+10.8%Reaction day
₹2.32
prior close
₹2.33
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.4%+9.3% vs market
Healthcare Service Provider peers, median of 24sector+0.8%+10.0% vs sector

On the reaction day the stock moved 9.3 pts more than Nifty Microcap 250 and 10.0 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
+2.6
30m
+2.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+10.8+1.4+9.3+0.8+10.0
Next day
+3.4+1.7+1.7+1.0+2.5
2d
+10.8+3.9+6.9+1.8+9.0
3d
+9.9pendingpending+1.7+8.2
4d
+9.1pendingpending+0.9+8.2
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Eswara Rao and Co resigned as statutory auditors effective 28 October 2026, citing a family medical emergency and insufficient time for the September quarter review. Appointed only on 10 October, it had started no audit work and reported no concerns about management. It had itself replaced Vasavi and Co, which resigned earlier. On 2 November, the board appointed Harish Gummadi and Co, subject to shareholder approval, until the next AGM.

Likely market impact

Rapid auditor changes may draw investor attention, but no audit or management concerns were reported. The successor still needs shareholder approval.